Teva Urges Justices To Reject Fed. Circ. On-Sale Bar Appeal
Teva Pharmaceuticals has urged the U.S. Supreme Court not to review the Federal Circuit's holding on the America Invents Act's changes to the on-sale bar rule, arguing Helsinn Healthcare is wrong...To view the full article, register now.
Already a subscriber? Click here to view full article